Press Releases

05 Dec
2018

PostProcess and CUBRC Partner to Accelerate Next Gen Post-Printing Software Platforms

Buffalo, NY, December 5th, 2018 - PostProcess Technologies (PPT) announced today a partnership with CUBRC, a leader in machine learning research, development, testing and systems integration, to leverage their cutting-edge Heartwood Analytics™ suite for PPT’s next-generation software platforms. As the pioneer of software-based 3D post-printing solutions driving automation for the third stage of Additive Manufacturing (AM), the partnership with CUBRC significantly advances PPT’s work on the full digitization of AM through the post-print step for the Industry 4.0 factory floor.

Read more ...
02 Oct
2018

CUBRC and EpiVax Awarded FDA Contract worth $1.0 Million to Perform In Silico Immunogenicity Risk Assessment of Generic Peptide Drugs and their Impurities

Buffalo, NY – October 2, 2018 – CUBRC, Inc.’s President and CEO, Tom McMahon, announced today that CUBRC, in collaboration with EpiVax, Inc., was awarded a two-year contract worth $1.0 million from the Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS).  The new program is relevant to the new draft guidance issued by the Office on Generic Drugs (OGD) highlighting the use of in silico analysis in accelerated new drug applications for generic peptide drugs [for additional info see link to FDA guidance here: FDA].

Read more ...
23 Feb
2018

CUBRC Awarded Contract from the Defense Threat Reduction Agency to Develop a Computational Predictive Toxicity System

fdfsdfs

Buffalo, NY–February 23, 2018

CUBRC Inc., a leading Research, Development, Testing and Systems Integration company, has been awarded a three-year, $4.1M contract from the Defense Threat Reduction Agency (DTRA) entitled, Computational Assessment of Compound Toxicity. The overall objective of this contract is to intelligently link chemical structure, physicochemical properties, biochemical properties and biological activity from multiple databases, assays, models and tools to provide accurate predictions of acute, debilitating chemical toxicity with enough confidence to alert of potential threats and to guide subsequent toxicity characterization efforts.

Read More
15 Mar
2017

CUBRC Partners With UB and Cobham to Advance Research That Will Aid Companies Make Better Use of Digital Manufacturing Data

fdfsdfs

Buffalo, NY

The University at Buffalo and the Chicago-based Digital Manufacturing and Design Innovation Institute (DMDII) have entered into an agreement to implement a $1.3 million project designed to create and test work flow innovations using a standard vocabulary and set of categories, forming what can be called a suite of ontologies, to support digital manufacturing for a local technology and services innovator.  

Read More

Mission Statement

CUBRC’s mission is to combine innovative ideas and state-of-the-art technology to help solve some of the most critical and challenging problems facing our Defense, Intelligence and Homeland Security communities.

  • CUBRC Headquarters
  • 1-866-91CUBRC (28272)
  • 4455 Genesee Street, Suite 106
    Buffalo, NY 14225
  • General Contact Form

Business Directory

  • Information Exploitation 716.204.5120
  • Chem, Bio & Medical 716.204.5116
  • Aeronautics 716.204.5125
  • Finance 716.204.5111
  • Human Resources 716.204.5111
  • Administration 716.204.5111